Revenue Grew 135% Year-over-Year; Adjusted EBITDA Improved to $0.71 Million PLAINVIEW, NY / ACCESSWIRE / May 13, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months ended March 31, 2016. “We are excited to report that during the first quarter 2016, the Company recorded $17.5 million of...
Read More

Management to Hold Investor Conference Call on May 13, 2016 at 10:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / May 6, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months ended March 31, 2016 on Friday, May 13, 2016, before market open. The Company will...
Read More

Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue PLAINVIEW, NY / ACCESSWIRE / March 29, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months and year ended December 31, 2015. “With a 63% year-over-year growth in annual revenue...
Read More

Management to Hold Investor Conference Call on March 29, 2016 at 10:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / March 22, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months and year ended December 31, 2015 on Tuesday, March 29, 2016, before market open. The...
Read More

PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. (“Vasomedical”) (VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare...
Read More